Bouthour, Walid
Bruce, Beau B.
Newman, Nancy J.
Biousse, Valérie https://orcid.org/0000-0002-3594-850X
Article History
Received: 27 May 2024
Revised: 4 October 2024
Accepted: 15 October 2024
First Online: 30 October 2024
Competing interests
: None of the authors have any competing interest. VB is consultant for GenSight Biologics, Neurophoenix and Topcon. NJN is consultant for GenSight Biologics, Santhera/Chiesi, Stoke, and Neurophoenix; receives research support from GenSight Biologics and Santhera/Chiesi. VB, NJN are supported by the National Institutes of Health’s National Eye Institute core grant P30-EY06360 (Department of Ophthalmology, Emory University School of Medicine) and by a departmental grant from Research to Prevent Blindness (New York, NY). WB received a scholarship from Geneva University Hospitals, Geneva, Switzerland.